Juan Celedón, MD, recently gave the Annual Nathan Francis Mossell Lecture at the University of Pennsylvania’s Perelman School of Medicine. The lecture is presented in recognition of the school’s first African American student, Nathan Mossell. Dr. Celedón’s presentation was titled “A Journey to Solve the Puzzle of Asthma Disparities.”
UPMC Physician Resources
A study led by Juan Celedon, MD; Yueh-Ying Han, PhD; and Erick Forno, MD, was recently published in the American Journal of Respiratory and Critical Care Medicine. This study aimed to examine adiposity, asthma, and fractional exhaled nitric oxide in children in the United States.
The full article is available here.
At this year’s Hawaiian Eye conference taking place from January 17 – 23, Joel S. Schuman, MD, FACS, will be presenting and moderating the Glaucoma session. Dr. Schuman’s presentation, How to Use OCT in Deciding Whether or Not to Intervene in Glaucoma, will share results of a recent study that showed with OCT we can detect glaucoma earlier than ever before.
Ocular Surgery News featured a summary of Dr. Schuman’s presentation online. It is available here.
The full list of presentations is available here.
Autologous alternative veins do not provide better mid term outcomes than prosthetic conduits for below knee bypass when great saphenous vein is unavailable
Efthymios Avgerinos, MD, presented “Autologous Alternative Veins do not Provide Better mid-term outcomes than Prosthetic Conduits for below knee bypass when Great Saphenous Vein is Unavailable” at the European Society of Vascular Surgery 2014 Meeting in Stockholm, Sweden.
He discussed how certain patients with peripheral vascular disease who need a surgical bypass can benefit from contemporary prosthetic conduits when great saphenous vein (the gold standard conduit) is unavailable. Current recommendations suggest that when great saphenous vein is unavailable in a patient needing a surgical bypass for limb salvage, an alternative vein (e.g. arm vein) should be preferred over a prosthetic graft. Usage of alternative veins requires a complex, lengthy, high risk procedure that may be associated with significant adverse events and multiple reinterventions.
Dr Avgerinos’ research identified a subgroup of patients for whom a prosthetic conduit can have equal if not better postoperative and mid-term outcomes. Using a prosthetic conduit minimizes the incisions needed and the operative time. Patients who should preferentially receive a prosthetic conduit would be those with multiple comorbidities and those whose bypass target is the below knee popliteal artery.
Read the abstract here.
Hear more about this work from Dr. Avgerinos:
The December “News You Can Use” column in Ocular Surgery News featured an article by Andrew Eller, MD. Dr. Eller discussed the benefits and who makes a good candidate for pneumatic retinopexy. The full article is available here.
What is the role and who is a good candidate?
What are the benefits to pneumatic retinopexy?
How does pneumatic retinopexy work?
What is the risk of a failed pneumatic retinopexy procedure?
Follow up questions for Dr. Eller can be directed to EyeCenter@upmc.edu
Donald Baril, MD, chief of vascular surgery at UPMC Mercy, has been named the medical director of the Vascular Quality Initiative’s (VQI) Great Lakes Vascular Study Group.
The VQI is overseen by the Society for Vascular Surgeons Patient Safety Organization which provides oversight of data sharing arrangements, quality measures, and distribution of information to participating providers and functions as a collective of regional quality groups gathering and evaluating data in an effort to improve the quality, safety and effectiveness of patient care.
The Great Lakes Vascular Study Group covers western Pennsylvania and parts of eastern Ohio.
The November News You Can Use column in Ocular Surgery News featured Ellen Mitchell, MD. Dr. Mitchell discussed nasolacrimal duct obstruction and various treatment methods. The full article is available on Ocular Surgery News.
1. What symptoms can a patient present with that may indicate a diagnosis of NLDO?
2.What does the conservative method of treating NLDO include?
3. What are the advantages of waiting for probing and irrigation?
4.What are the available treatment options if symptoms recur ?
Questions or comments can be directed to Dr. Mitchell at EyeCenter@upmc.edu.
The October “News You Can Use” column featured an article from new UPMC Eye Center faculty member Ladan Espandar, MD. Dr. Espandar discussed neurotrophic keratopathy. The full article is available here.
What is neurotrophic keratopathy and what causes it?
What are the clinical findings and how do they differ?
How is this condition treated?
Questions can be directed to Dr. Espandar at EyeCenter@upmc.edu
Right-ventricular Dysfunction and Prognosis in Patients with Low-flow, Low-gradient Severe Aortic Stenosis
João Cavalcante, MD, presented “Right-ventricular dysfunction and prognosis in patients with low-flow, low-gradient severe aortic stenosis,” at the European Society of Cardiology 2014 Meeting in Barcelona, Spain. He discussed how assessment of aortic stenosis (AS) severity is critical for treatment decisions but challenging in patients with severe AS and low gradients. The research further examines the importance of the interplay between the two ventricles in patients with aortic stenosis and heart failure.
Read the full abstract here (page 250).
Hear more about this work from Dr. Cavalcante: